These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10533830)

  • 1. Use of blood therapeutically drawn from hemochromatosis patients. Council on Scientific Affairs, American Medical Association.
    Tan L; Khan MK; Hawk JC
    Transfusion; 1999 Sep; 39(9):1018-26. PubMed ID: 10533830
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center.
    Gribble DM; Chaffin DJ; Bryant BJ
    Immunohematology; 2009; 25(4):170-3. PubMed ID: 20406025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous blood transfusions. Council on Scientific Affairs.
    JAMA; 1986 Nov; 256(17):2378-80. PubMed ID: 3773142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary hemochromatosis HFE: regulatory and economic aspects of diagnosis and medical management].
    Ropert-Bouchet M; Fajardy I; Michel H
    Ann Biol Clin (Paris); 2012; 70(4):405-11. PubMed ID: 22796612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis.
    Sanchez AM; Schreiber GB; Bethel J; McCurdy PR; Glynn SA; Williams AE; Gilcher R;
    JAMA; 2001 Sep; 286(12):1475-81. PubMed ID: 11572740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis blood donor programs: marginal for the red blood cell supply but potentially good for patient care.
    Newman B
    Transfusion; 2004 Oct; 44(10):1535-7; author reply 1537-8. PubMed ID: 15383032
    [No Abstract]   [Full Text] [Related]  

  • 7. Crossover use of donated blood for autologous transfusion: report of the Council on Scientific Affairs, American Medical Association.
    Blum LN; Allen JR; Genel M; Howe JP
    Transfusion; 1998 Sep; 38(9):891-5. PubMed ID: 9738632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion with blood from people with HFE gene mutations.
    Anía BJ; Rodríguez-Gallego C
    Lancet; 1999 Jul; 354(9176):430. PubMed ID: 10437908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Utilization of blood arising from therapeutic bleeding of genetic hemochromatosis].
    Bourel M; Deugnier Y
    Bull Acad Natl Med; 1992 Apr; 176(4):487-90. PubMed ID: 1504869
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on predeposit autologous blood donation and transfusion in Europe.
    Politis C; Richardson SC
    Vox Sang; 2004 Aug; 87(2):105-8. PubMed ID: 15355501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis probands as blood donors.
    Barton JC; Grindon AJ; Barton NH; Bertoli LF
    Transfusion; 1999 Jun; 39(6):578-85. PubMed ID: 10378837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary hemochromatosis (genetic or idiopathic). A publication for physicians by the Hemochromatosis Research Foundation Inc].
    Rev Invest Clin; 1985; 37(4):395-8. PubMed ID: 3912879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determining donor eligibility and donor suitability of hemochromatosis marker carriers ].
    Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1349-50. PubMed ID: 26487383
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemochromatosis patients are untapped source of blood as war, shortages loom.
    Voelker R
    JAMA; 2003 Mar; 289(11):1364-6. PubMed ID: 12636439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic hemochromatosis and donation of blood. Synthesis of a multidisciplinary Work Group (January 2001)].
    Courtois F; Danic B
    Rev Med Interne; 2001 Dec; 22(12):1165-7. PubMed ID: 11794884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of hereditary hemochromatosis by gastroenterologists in general hospitals. Results of a National Association of Gastroenterologists study].
    Barbare JC; Nouel O
    Gastroenterol Clin Biol; 2002; 26(6-7):636-7. PubMed ID: 12193866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemochromatosis].
    Lefrère F
    Rev Prat; 2007 Dec; 57(20):2291-6. PubMed ID: 18320752
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to confirm and treat hemochromatosis in 2002?].
    Brissot P; Lainé F; Guillygomarc'h A; Guyader D; Loréal O; Deugnier Y; Moirand R
    Journ Annu Diabetol Hotel Dieu; 2002; ():69-82. PubMed ID: 12525132
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Screening for hereditary hemochromatosis: recommendations from the American College of Physicians.
    Ann Intern Med; 2005 Oct; 143(7):I46. PubMed ID: 16204158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hereditary hemochromatosis. Problems in diagnosis and treatment].
    Altés A; Sanz C; Bruguera M
    Med Clin (Barc); 2015 May; 144(9):424-8. PubMed ID: 25577588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.